======= LSM2 =======
== Gene Information ==
* **Official Symbol**: LSM2
* **Official Name**: LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57819|57819]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y333|Q9Y333]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LSM2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LSM2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607282|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Binds specifically to the 3'-terminal U-tract of U6 snRNA. May be involved in pre-mRNA splicing.
|LSM|
|Lsm1-7-Pat1 complex|
|Lsm2-8 complex|
|U6 snRNP|
|U6 snRNA binding|
|Ral GTPase binding|
|U4/U6 x U5 tri-snRNP complex|
|exonucleolytic catabolism of deadenylated mRNA|
|nuclear-transcribed mRNA catabolic process, exonucleolytic|
|U2-type precatalytic spliceosome|
|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|
|catalytic step 2 spliceosome|
|P-body|
|nuclear-transcribed mRNA catabolic process|
|mRNA catabolic process|
|RNA catabolic process|
|mRNA splicing, via spliceosome|
|RNA splicing, via transesterification reactions with bulged adenosine as nucleophile|
|RNA splicing, via transesterification reactions|
|nucleobase-containing compound catabolic process|
|RNA splicing|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|aromatic compound catabolic process|
|mRNA processing|
|organic cyclic compound catabolic process|
|mRNA metabolic process|
|RNA processing|
|cellular macromolecule catabolic process|
|macromolecule catabolic process|
|RNA binding|
|RNA metabolic process|
|negative regulation of gene expression|
|organic substance catabolic process|
|cellular catabolic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.92|
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.91|
|[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|-1.74|
|[[:results:exp303|39°C R06 exp303]]|1.83|
|[[:results:exp210|LB-100 2μM R05 exp210]]|1.84|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 739/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|28/28|
|blood|28/28|
|bone|26/26|
|breast|33/33|
|central nervous system|56/56|
|cervix|4/4|
|colorectal|17/17|
|esophagus|13/13|
|fibroblast|1/1|
|gastric|16/16|
|kidney|21/21|
|liver|20/20|
|lung|75/75|
|lymphocyte|16/16|
|ovary|26/26|
|pancreas|24/24|
|peripheral nervous system|16/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|24/24|
|soft tissue|9/9|
|thyroid|2/2|
|upper aerodigestive|22/22|
|urinary tract|29/29|
|uterus|5/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1720
* **Expression level (log2 read counts)**: 4.95
{{:chemogenomics:nalm6 dist.png?nolink |}}